reboxetine has been researched along with Disease Models, Animal in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 15 (53.57) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ciucci, MR; Hoffmeister, JD; Kelm-Nelson, CA | 1 |
| Belloch, FB; Cortés-Erice, M; Díaz-Perdigon, T; Herzog, E; Puerta, E; Tordera, RM; Zhang, XM | 1 |
| Lenda, T; Pałucha-Poniewiera, A; Pilc, A; Podkowa, K | 1 |
| Bagińska, M; Barut, J; Chmielarz, P; Daniel, WA; Kot, M; Kreiner, G; Nalepa, I; Parlato, R; Rafa-Zabłocka, K | 1 |
| Caso, JR; García-Bueno, B; González-Prieto, M; Gutiérrez, IL; Leza, JC; Madrigal, JLM | 1 |
| De Bundel, D; DuPont, CM; Feltmann, K; Femenía, T; Konradsson-Geuken, Å; Lindskog, M; Schilström, B | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S | 1 |
| Borowicz, KK; Borowicz, KM; Latalski, M; Zarczuk, R | 1 |
| Bhagya, V; Raju, TR; Shankaranarayana Rao, BS; Srikumar, BN | 1 |
| Krakowska, A; Mlyniec, K; Nowak, G; Opoka, W; Ostachowicz, B; Reczynski, W | 1 |
| Dudka, J; Kasperek, R; Nowak, G; Poleszak, E; Serefko, A; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A | 1 |
| Ampuero, E; Cavada, G; Diaz-Veliz, G; Luarte, A; Rubio, FJ; Santibañez, M; Toledo, J; Varas-Godoy, M; Wyneken, U | 1 |
| Borowicz, KK; Popławska, M; Wróblewska, D | 1 |
| Fendt, M; Leibiger, J; Schmidt, C | 1 |
| Andreasen, JT; Olsen, GM; Redrobe, JP; Wiborg, O | 1 |
| Andreasen, JT; Redrobe, JP | 1 |
| Frishtick, R; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I; Weizman, R | 1 |
| Enkel, T; Gass, P; Gholizadeh, D; Hurlemann, R; Sanchis-Segura, C; Spanagel, R; Vollmayr, B; von Bohlen Und Halbach, O | 1 |
| Björkholm, C; Jardemark, K; Malmerfelt, A; Marcus, MM; Svensson, TH | 1 |
| Clinckers, R; Massie, A; Smolders, I; Vermoesen, K | 1 |
| Bodie, B; Herman, JP; Renda, A | 1 |
| Conklin, D; Eisenach, JC; Obata, H | 1 |
| Liles, LC; Schank, JR; Weinshenker, D | 1 |
| Ahern, TH; Eagles, DA; Javors, MA; Liles, LC; Martillotti, J; Mitchell, HA; Weinshenker, D | 1 |
| Blackburn-Munro, G; Nielsen, AN; Pedersen, LH | 1 |
| Abumaria, N; Flügge, G; Fuchs, E; Havemann-Reinecke, U; Hiemke, C; Rüther, E; Rygula, R; Zernig, G | 1 |
| Leonard, BE | 1 |
| Connor, TJ; Dredge, K; Harkin, A; Kelly, JP; Leonard, BE; McNamara, M; Redmond, A | 1 |
1 review(s) available for reboxetine and Disease Models, Animal
| Article | Year |
|---|---|
Noradrenaline in basic models of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Depressive Disorder; Disease Models, Animal; Humans; Morpholines; Olfactory Bulb; Reboxetine; Receptors, Adrenergic; Stress, Psychological | 1997 |
27 other study(ies) available for reboxetine and Disease Models, Animal
| Article | Year |
|---|---|
Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Atomoxetine Hydrochloride; Disease Models, Animal; Humans; Male; Norepinephrine; Parkinson Disease; Protein Kinases; Rats; Rats, Long-Evans; Reboxetine; Vocalization, Animal | 2022 |
Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Glutamic Acid; Ketamine; Mice; Neurons; Prefrontal Cortex; Reboxetine; Vesicular Glutamate Transport Protein 1 | 2023 |
The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test.
Topics: alpha-Methyltyrosine; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Membrane Transport Modulators; Mice, Inbred C57BL; Morpholines; Motor Activity; Norepinephrine; Reboxetine; Scopolamine; Serotonin | 2017 |
Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopaminergic Neurons; Female; Imidazoles; Immunohistochemistry; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Reboxetine; Substantia Nigra; Ventral Tegmental Area | 2019 |
Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Axons; Biomarkers; Chemokine CCL2; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Nerve Degeneration; Reboxetine | 2019 |
Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Cognition; Depression; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Hippocampus; Male; Morpholines; Motor Activity; Nootropic Agents; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Dopamine D1; Receptors, Dopamine D5; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Swimming; Time Factors | 2013 |
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride | 2013 |
Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Disease Models, Animal; Drug Interactions; Electroshock; Epilepsy; Male; Memory, Long-Term; Mice; Morpholines; Motor Activity; Phenobarbital; Phenytoin; Reboxetine; Valproic Acid | 2014 |
The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression.
Topics: Acetylcholinesterase; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Monoamines; Depression; Disease Models, Animal; Electric Stimulation; Female; Food Preferences; Hippocampus; In Vitro Techniques; Learning Disabilities; Male; Morpholines; Neuronal Plasticity; Rats; Rats, Wistar; Reboxetine; Spatial Learning; Swimming | 2015 |
Chronic but not acute antidepresant treatment alters serum zinc/copper ratio under pathological/zinc-deficient conditions in mice.
Topics: Animals; Antidepressive Agents; Bupropion; Citalopram; Copper; Depression; Disease Models, Animal; Imipramine; Male; Mice; Morpholines; Reboxetine; Sodium Chloride; Zinc | 2014 |
The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drug Synergism; Fluoxetine; Imipramine; Mice; Morpholines; Piperidines; Reboxetine; Swimming; Thiazepines | 2014 |
Two Chronic Stress Models Based on Movement Restriction in Rats Respond Selectively to Antidepressant Drugs: Aldolase C As a Potential Biomarker.
Topics: Animals; Antidepressive Agents; Chronic Disease; Depressive Disorder; Disease Models, Animal; Fluoxetine; Fructose-Bisphosphate Aldolase; Green Fluorescent Proteins; Male; Morpholines; Rats, Sprague-Dawley; Reboxetine; Restraint, Physical; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Stress, Psychological | 2015 |
Interactions between an antidepressant reboxetine and four classic antiepileptic drugs in the mouse model of myoclonic seizures.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Avoidance Learning; Clonazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Ethosuximide; Male; Mice; Morpholines; Motor Skills; Pentylenetetrazole; Phenobarbital; Reboxetine; Valproic Acid | 2015 |
The norepinephrine reuptake inhibitor reboxetine is more potent in treating murine narcoleptic episodes than the serotonin reuptake inhibitor escitalopram.
Topics: Adrenergic Uptake Inhibitors; Animals; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Narcolepsy; Orexins; Reboxetine; Selective Serotonin Reuptake Inhibitors; Time Factors | 2016 |
Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Female; Mice; Mice, Inbred Strains; Morpholines; Motor Activity; Nicotinic Agonists; Nicotinic Antagonists; Reboxetine | 2009 |
Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Mecamylamine; Mice; Morpholines; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Reboxetine; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Serotonin | 2009 |
The antinociceptive properties of reboxetine in acute pain.
Topics: Adrenergic Antagonists; Analgesics; Animals; Antidepressive Agents; Clonidine; Disease Models, Animal; Drug Interactions; Male; Mice; Mice, Inbred ICR; Morphine; Morpholines; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Reboxetine; Receptors, Opioid, mu | 2009 |
Ambiguous-cue interpretation is biased under stress- and depression-like states in rats.
Topics: Adrenergic Uptake Inhibitors; Amygdala; Analysis of Variance; Animals; Behavior, Animal; Bias; Conditioning, Psychological; Corticosterone; Cross-Over Studies; Cues; Depression; Discrimination, Psychological; Disease Models, Animal; Extinction, Psychological; Feeding Behavior; Food Preferences; Hippocampus; Male; Morpholines; Proto-Oncogene Proteins c-fos; Rats; Reboxetine; Stress, Psychological | 2010 |
Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Cerebral Cortex; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Agonists; Freezing Reaction, Cataleptic; In Vitro Techniques; Male; Membrane Potentials; Microdialysis; Morpholines; N-Methylaspartate; Olanzapine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reboxetine; Receptors, N-Methyl-D-Aspartate | 2010 |
The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy.
Topics: Animals; Antidepressive Agents; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Kainic Acid; Male; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Seizures; Status Epilepticus; Time Factors; Treatment Outcome; Video Recording | 2012 |
Norepinephrine-gamma-aminobutyric acid (GABA) interaction in limbic stress circuits: effects of reboxetine on GABAergic neurons.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Limbic System; Male; Morpholines; Neurons; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Reboxetine; Stress, Physiological | 2003 |
Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity after surgery in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atropine; Behavior, Animal; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drosophila Proteins; Drug Interactions; Hyperalgesia; Idazoxan; Male; Morpholines; Muscarinic Antagonists; Pain Threshold; Pain, Postoperative; Peptides; Rats; Rats, Sprague-Dawley; Reboxetine; Snail Family Transcription Factors; Spinal Cord; Time Factors; Transcription Factors | 2005 |
Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Anticonvulsants; Disease Models, Animal; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Drug Combinations; Flurothyl; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Norepinephrine; Reaction Time; Reboxetine; Seizures; Valproic Acid | 2005 |
The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Disease Models, Animal; Dopamine beta-Hydroxylase; Drug Administration Schedule; Electroshock; Flurothyl; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Pentylenetetrazole; Reaction Time; Reboxetine; Seizures | 2006 |
Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain.
Topics: Amines; Analgesics; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Constriction; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Male; Morpholines; Motor Activity; Neurotransmitter Uptake Inhibitors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reboxetine; Rotarod Performance Test; Spinal Cord Injuries; Vesicular Monoamine Transport Proteins | 2005 |
Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Male; Morpholines; Motivation; Motor Activity; Rats; Rats, Wistar; Reboxetine; Reward; Stress, Psychological | 2008 |
Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amygdala; Analgesics; Animals; Antidepressive Agents; Body Temperature; Clonidine; Depression; Disease Models, Animal; Drug Therapy, Combination; Exploratory Behavior; Hydroxyindoleacetic Acid; Male; Morpholines; Motor Activity; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Reboxetine; Serotonin Receptor Agonists; Sertraline; Swimming | 1999 |